Albireo Pharma (ALBO) Secures $55M Milestone Payment from EA Pharma Following NDA Approval in Japan for Elobixbat
Tweet Send to a Friend
Albireo Pharma, Inc. (NASDAQ: ALBO) today announced that Japan’s Ministry of Health, Labor and Welfare (MHLW) has approved the new ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
